Compounds > propiolactone

propiolactone and Hemophilia B

propiolactone has been researched along with Hemophilia B in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brackmann, HH; Kaiser, R; Kupfer, B; Matz, B; Oldenburg, J; Schneweis, KE1
Bailly, E; Brackmann, HH; Hammerstein, U; Hanfland, P; Kleim, JP; Oldenburg, J; Schneweis, KE; van Loo, B1

Other Studies

2 other study(ies) available for propiolactone and Hemophilia B

ArticleYear
Beta-propiolactone UV inactivated clotting factor concentrate is the source of HIV-infection of 8 hemophilia B patients: confirmed.
    Thrombosis and haemostasis, 1995, Volume: 74, Issue:5

    Topics: Base Sequence; Blood Coagulation Factors; Hemophilia B; HIV Infections; Humans; Molecular Sequence Data; Propiolactone

1995
Acute HIV-1 infection in patients with hemophilia B treated with beta-propiolactone-UV-inactivated clotting factor.
    Thrombosis and haemostasis, 1990, Oct-22, Volume: 64, Issue:2

    Topics: Blood Coagulation Factors; Drug Contamination; Gene Products, gag; Hemophilia B; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Propiolactone; Ultraviolet Rays; Viral Core Proteins

1990